Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne

NCT04709289 is registered in ClinicalTrials.gov with Shanghai Dermatology Hospital as lead sponsor.

NCT NCT04709289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04709289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne
Lead sponsor
Shanghai Dermatology Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2020
Completion date
February 28, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris